Clinical Trial Update: Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of two doses of tiotropium via Respimat compared with placebo in adolescents with moderate persistent asthma; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Spiriva (tiotropium)
• tiotropium (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2014-08-08